Hepatocellular carcinoma surgery outcomes in the developing world: A 20-year retrospective cohort study at the National Cancer Institute of Peru

@article{Ruiz2016HepatocellularCS,
  title={Hepatocellular carcinoma surgery outcomes in the developing world: A 20-year retrospective cohort study at the National Cancer Institute of Peru},
  author={Eloy Ruiz and Teresa Rojas Rojas and Francisco Berrospi and Ivan Chavez and Carlos Luque and Luis Cano and Franco Doimi and Pascal Pineau and Eric Deharo and St{\'e}phane Bertani},
  journal={Heliyon},
  year={2016},
  volume={2}
}
In the developing world, most patients with hepatocellular carcinoma present with advanced-stage disease, considered to be incurable based on current therapeutic algorithms. Here, we demonstrate that curative liver resection is achievable in a portion of Peruvian patients not addressed by these treatment algorithms. We conducted a retrospective cohort study of 253 hepatocellular carcinoma patients that underwent a curative hepatectomy between 1991 and 2011 at the National Cancer Institute of… Expand
Short-term outcomes after hepatic resection : perspective from a developing country.
TLDR
Morbidity, mortality and blood loss were comparatively higher in cirrhotic patients than in normal patients, and the presence of one or more co-morbid conditions had a statistically significant association with postoperative morbidity. Expand
Liver clear cell foci and viral infection are associated with non-cirrhotic, non-fibrolamellar hepatocellular carcinoma in young patients from South America
TLDR
The findings confirm the occurrence of a particular setting of HCC in South America, a region where the pathophysiology of liver cancer remains largely unexplored. Expand
A Seven-Year Retrospective Study on the Surveillance of Hepatitis B in Laos
TLDR
Public health decisions should be taken urgently to rationalise vaccination and provide fair access to early diagnosis and treatment; otherwise the burden of HBV-associated diseases will be overwhelming for Laos in the near future. Expand
On hepatocellular carcinoma in South America and early-age onset of the disease.
TLDR
The current knowledge on HCC presentation in Peru is reviewed, highlighting the well-documented occurrence of an early-age nosological form of the disease in Andean descent populations and the implications for liver cancer screening, management, and prevention. Expand
Early-onset liver cancer in South America associates with low hepatitis B virus DNA burden
TLDR
It is concluded that in Peru, and maybe in other populations with Americas’ indigenous ancestry, HBV-associated liver tumorigenesis might differ significantly from that generally observed in the rest of the world. Expand
Temporal trends and regional variations in gastrointestinal cancer mortality in Peru, 2005-2014.
TLDR
Stomach cancer remains the most frequent GI cancer, but with a downward trend in the study period, and the GI cancer age-standarized mortality rates at the country level showed a decrease of 12.70% between 2005-2014. Expand
Herbal Medicine Practices of Patients With Liver Cancer in Peru: A Comprehensive Study Toward Integrative Cancer Management
TLDR
It is confirmed that HM remains one of the principal primary health care resources in Peru, even for a severe disease like liver cancer, and traditional, complementary and alternative medicine practices should be taken into consideration in Peruvian health programs aiming to educate the population in cancer prevention and treatment, as well as integrative cancer management. Expand
Metallomic profile in non-cirrhotic hepatocellular carcinoma supports a phenomenon of metal metabolism adaptation in tumor cells
TLDR
The data, obtained in Peruvian and French HCC-NC cohorts, highlights similarity in the metallomic profile of HCC compared to NTL during the hepatic tumorigenesis in these specific groups of patients. Expand
Surgical Infections in Low- and Middle-Income Countries: A Global Assessment of the Burden and Management Needs.
TLDR
Surgical infections comprise a broad range of diseases including intra-abdominal, skin and soft tissue, and healthcare-associated infections and other infectious processes and constitute a large burden of disease globally. Expand
Global DNA hypermethylation pattern and unique gene expression signature in liver cancer from patients with Indigenous American ancestry
TLDR
Integrative characterization revealed that Peruvian HCC is apparently controlled by the PRC2 complex that mediates cell reprogramming with massive DNA methylation modulating gene expression and pinpointed retinoid signaling as a potential target for epigenetic therapy. Expand
...
1
2
...

References

SHOWING 1-10 OF 72 REFERENCES
Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patients
TLDR
Results in survival are much improved over the past reports, and the differences are probably a result of earlier diagnosis and frequent hepatic resection, probably due to the coexistent advanced cirrhosis. Expand
A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients
TLDR
The aims of this study were to verify the value of known prognostic factors and to devise a prognostic index more sensitive than the commonly used Okuda stage, and to produce a new prognostic system that accounts for both liver function and tumor characteristics. Expand
Surgical treatment for large hepatocellular carcinoma: does size matter?
TLDR
Identifying the risk factors that affect the outcome in patients undergoing surgery for large HCC is critical, because surgical resection can have excellent outcomes in carefully selected patients. Expand
Applicability of the BCLC staging system to patients with hepatocellular carcinoma in Korea: analysis at a single center with a liver transplant center
TLDR
Donor shortage, financial problems, the relatively limited efficacy of molecular targeting agents, and the presence of an indeterminate nodule were the main causes of deviation from BCLC recommendations. Expand
Evaluation of Eight Different Clinical Staging Systems Associated with Overall Survival of Chinese Patients with Hepatocellular Carcinoma
TLDR
Barcelona Clinic Liver Cancer staging system is a better staging model for HBV infection patients with HCC in Chinese population among the eight currently used staging systems. Expand
Adherence to AASLD guidelines for the treatment of hepatocellular carcinoma in clinical practice: experience of the Bologna Liver Oncology Group.
  • S. Leoni, F. Piscaglia, +7 authors L. Bolondi
  • Medicine
  • Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
  • 2014
TLDR
Overall, 60% of patients were treated according to American Association for the Study of Liver Diseases guidelines, and approximately 28% of hepatocellular carcinomas were "under-treated" and 7% treated more aggressively than recommended. Expand
Microvascular Invasion Does Not Predict Long-Term Survival in Hepatocellular Carcinoma up to 2 cm: Reappraisal of the Staging System for Solitary Tumors
TLDR
Small HCC is associated with an excellent prognosis that is not affected by the presence of MVI, and the discriminatory power of the 7th edition of the AJCC classification for solitary HCC could be further improved by subdividing tumors according to size. Expand
Application of the Barcelona Clinic Liver Cancer therapeutic strategy and impact on survival
TLDR
In real-life practice one-third of HCC patients could not receive first-line BCLC treatment, and similar short and medium-term survival was observed in this cohort of patients. Expand
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.
TLDR
The present document gives up-dated guidelines for the current clinical practice, and an overview of those aspects that should be the target of future clinical research. Expand
Prognosis of hepatocellular carcinoma: the BCLC staging classification.
TLDR
A new staging system is proposed, the Barcelona Clinic Liver Cancer (BCLC) staging classification, that comprises four stages that select the best candidates for the best therapies currently available, based on prognostic factors obtained from studies performed years ago. Expand
...
1
2
3
4
5
...